CAS NO: | 147821-57-6 |
包装 | 价格(元) |
5mg | 电议 |
10mg | 电议 |
50mg | 电议 |
100mg | 电议 |
生物活性 | Niazinin is a thiocarbamate glycoside with antileishmanial activities, with anIC50value of 5.25 μM. Niazinin also shows a binding affinity with the target protein3CL protease. Niazinin has promising leishmanicidal, anti-inflammatory and anti-pyretic activity[1][2]. | ||||||||||||||||
体外研究 (In Vitro) | Niazinin, is cytotoxic at substantially higher concentration (CC50 of 31.6 μM) than its antileishmanial concentration (IC50 of 5.25 μM)[1]. | ||||||||||||||||
分子量 | 343.40 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C15H21NO6S | ||||||||||||||||
CAS 号 | 147821-57-6 | ||||||||||||||||
结构分类 |
| ||||||||||||||||
来源 |
| ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 | 4°C, protect from light *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light) | ||||||||||||||||
溶解性数据 | In Vitro: DMSO : ≥ 50 mg/mL(145.60 mM) *"≥" means soluble, but saturation unknown. 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
|